Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meenakshi Jeeva
Observed names:
Jeeva M,
M Jeeva,
M. Jeeva,
Meenakshi Nivedha J.
Institutions:
University Health Network,
University of Toronto,
Homi Bhabha National Institute,
Tata Memorial Hospital,
Princess Margaret Cancer Centre,
Advanced Centre for Treatment, Research and Education in Cancer
show all 6
Observed institutions:
University Health Network,
University of Toronto,
Homi Bhabha National Institute,
Tata Memorial Hospital,
Princess Margaret Cancer Centre,
Advanced Centre for Treatment, Research and Education in Cancer,
KCG College of Technology
show all 7
ORCID:
0000-0002-4359-4916
Observed ORCID:
0000-0002-4359-4916
OpenAlex ID:
A5031516623
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched‐pair analysis
2023
·
Sarbani Ghosh Laskar
, Shwetabh Sinha
, et al.
·
Head & Neck
·
4
PDF
Prophylactic Versus Reactive ( PvR ) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial
2025
·
Sarbani Ghosh Laskar
, Shwetabh Sinha
, et al.
·
Head & Neck
·
3
PDF
Subsequent Neoplasm Risk After Modern Mediastinal Radiation Therapy for Pediatric Hodgkin Lymphoma: Insights From a Multi-Institutional Children’s Oncology Group Trial
2026
·
Sarah A. Milgrom
, Harald Paganetti
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
Hybridization of ML techniques for predicting Breast Cancer
2022
·
Jeeva M
, Padmapriya E
, et al.
·
International Conference on Intelligent Computing, Instrumentation and Control Technologies (ICICICT)
·
2
Liver-Directed Therapy for Colorectal Cancer: Where Are We Now?
2026
·
Yi Song
, Meenakshi Jeeva
, et al.
·
American Society of Clinical Oncology Educational Book
·
1
Third Course of Radical Intent Conformal Radiation in Patients with Primary Brain Tumors
2025
·
M. Jeeva
, A. Dasgupta
, et al.
·
Clinical Oncology
·
1
Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma
2026
·
Inna Y. Gong
, Naomi M. Xiao
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Outcomes of patients with primary refractory and early relapsing large B-cell lymphoma are inferior in the CD19 CAR T era
2026
·
Inna Y. Gong
, Massimiliano Marinoni
, et al.
·
Blood Immunology & Cellular Therapy
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third‐Line CAR T
2026
·
Inna Y. Gong
, Meenakshi Jeeva
, et al.
·
Hematological Oncology
H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era
2026
·
Meenakshi Jeeva
, Mamta Gurav
, et al.
·
Neuro-Oncology Advances
Predicted Breast Cancer Risk after Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Analysis of a Multi-Institutional Children’s Oncology Group Trial
2025
·
S A Milgrom
, H Paganetti
, et al.
·
Klinische Pädiatrie
Radiotherapy consolidation post-autologous stem cell transplant in Relapsed/Refractory aggressive non-Hodgkin lymphoma improves progression-free and overall survival in patients with partial but not complete metabolic response pre-transplant
2025
·
Joshua Yi
, Chathuri Abeyakoon
, et al.
·
Blood
PDF
Outcomes From a Contemporary Mono-Institutional Cohort of Histone-Mutant Diffuse Hemispheric Glioma: A Rare and Aggressive Pediatric-Type High-Grade Primary Brain Tumor
2025
·
Meenakshi Jeeva
, Mamta Gurav
, et al.
·
Brain Tumor Research and Treatment
PDF
Show more works
View as search
Works count:
13
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type